Anti-EDEM2 antibody [EPR14043-24] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal EDEM2 antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
C20orf31, C20orf49, UNQ573/PRO1135, EDEM2, ER degradation-enhancing alpha-mannosidase-like protein 2
- WB
Supplier Data
Western blot - Anti-EDEM2 antibody [EPR14043-24] - BSA and Azide free (AB250219)
This data was developed using ab180522, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-EDEM2 antibody [EPR14043-24] (<a href='/en-us/products/primary-antibodies/edem2-antibody-epr14043-24-ab180522'>ab180522</a>) at 1/10000 dilution
All lanes:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 65 kDa
false
- WB
Supplier Data
Western blot - Anti-EDEM2 antibody [EPR14043-24] - BSA and Azide free (AB250219)
This data was developed using ab180522, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-EDEM2 antibody [EPR14043-24] - BSA and Azide free (ab250219) at 1/2000 dilution
All lanes:
IM9 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 65 kDa
false
Reactivity data
Product details
ab250219 is the carrier-free version of ab180522.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EDEM2 helps ensure protein quality control within cells. It works as part of the ERAD system by targeting misfolded glycoproteins for degradation preventing accumulation of defective proteins that could be harmful to cells. EDEM2 does not act alone but instead functions together with other molecular chaperones and lectin-like proteins to identify and process substrates. This cooperation is essential for maintaining cellular homeostasis and avoiding stress responses.
Pathways
EDEM2 links closely with both protein foldings and quality control mechanisms. It directly interacts with ERAD pathways promoting the disassembly of structurally improper glycoproteins. The action of EDEM2 in these pathways connects with other proteins like SEL1L and HRD1 forming a network that handles aberrant proteins.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
OncoTargets and therapy 13:13315-13327 PubMed33408482
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com